Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System

V. Panebianco, A. Briganti, TN. Boellaard, J. Catto, E. Comperat, J. Efstathiou, AG. van der Heijden, G. Giannarini, R. Girometti, L. Mertens, M. Takeuchi, VF. Muglia, Y. Narumi, G. Novara, M. Pecoraro, M. Roupret, F. Sanguedolce, D. Santini, SF....

. 2024 ; 21 (4) : 243-251. [pub] 20231130

Language English Country England, Great Britain

Document type Journal Article, Review

E-resources Online Full text

NLK ProQuest Central from 2009-04-01 to 1 year ago
Health & Medicine (ProQuest) from 2009-04-01 to 1 year ago

Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.

Academic Urology Unit University of Sheffield Sheffield UK

Department of Healthcare Tachibana University Kyoto Japan

Department of Medical Images Radiation Therapy and Oncohematology Ribeirao Preto Medical School University of Sao Paulo Ribeirao Preto Brazil

Department of Medical Surgical and Experimental Sciences University of Sassari Sassari Italy

Department of Medical Surgical Sciences and Biotechnologies Sapienza University Latina Italy

Department of Pathology Sorbonne University Assistance Publique Hôpitaux de Paris Hopital Tenon Paris France

Department of Radiation Oncology Massachusetts General Hospital Harvard Medical School Boston MA USA

Department of Radiological Sciences Oncology and Pathology Sapienza University of Rome Rome Italy

Department of Radiology and Nuclear Medicine Radboudumc Nijmegen The Netherlands

Department of Radiology Memorial Sloan Kettering Cancer Center New York NY USA

Department of Radiology Netherlands Cancer Institute Amsterdam The Netherlands

Department of Radiology Radiolonet Tokai Nagoya Japan

Department of Surgery Oncology and Gastroenterology Urology Clinic University of Padua Padua Italy

Department of Surgical Oncology Netherlands Cancer Institute Amsterdam The Netherlands

Department of Urology Comprehensive Cancer Center Medical University Vienna Vienna General Hospital Vienna Austria

Department of Urology Fundació Puigvert Autonomous University of Barcelona Barcelona Spain

Department of Urology Radboud University Medical Center Nijmegen The Netherlands

Department of Urology Sorbonne University AP HP Pitié Salpétrière Hospital Paris France

Department of Urology Teaching Hospital Motol and 2nd Faculty of Medicine Charles University Praha Prague Czech Republic

Division of Medical Oncology A Policlinico Umberto 1 Rome Italy

Institute of Radiology Academic Medical Centre Santa Maria della Misericordia Udine Italy

IRCCS Regina Elena National Cancer Institute Department of Urology Rome Italy

Unit of Urology Division of Oncology Urological Research Institute IRCCS Ospedale San Raffaele Vita Salute San Raffaele University Milan Italy

Urology Unit Academic Medical Centre Santa Maria della Misericordia Udine Italy

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014503
003      
CZ-PrNML
005      
20240905134225.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41585-023-00830-2 $2 doi
035    __
$a (PubMed)38036666
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Panebianco, Valeria $u Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy. valeria.panebianco@uniroma1.it $1 https://orcid.org/000000018466918X
245    10
$a Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System / $c V. Panebianco, A. Briganti, TN. Boellaard, J. Catto, E. Comperat, J. Efstathiou, AG. van der Heijden, G. Giannarini, R. Girometti, L. Mertens, M. Takeuchi, VF. Muglia, Y. Narumi, G. Novara, M. Pecoraro, M. Roupret, F. Sanguedolce, D. Santini, SF. Shariat, G. Simone, HA. Vargas, S. Woo, J. Barentsz, JA. Witjes
520    9_
$a Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.
650    _2
$a lidé $7 D006801
650    12
$a močový měchýř $x diagnostické zobrazování $7 D001743
650    _2
$a magnetická rezonanční tomografie $x metody $7 D008279
650    12
$a nádory močového měchýře $x diagnostické zobrazování $7 D001749
650    _2
$a výzkumný projekt $7 D012107
650    _2
$a konsensus $7 D032921
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Briganti, Alberto $u Unit of Urology/Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
700    1_
$a Boellaard, Thierry N $u Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
700    1_
$a Catto, James $u Academic Urology Unit, University of Sheffield, Sheffield, UK
700    1_
$a Comperat, Eva $u Department of Pathology, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Hopital Tenon, Paris, France
700    1_
$a Efstathiou, Jason $u Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA $1 https://orcid.org/0000000309960350
700    1_
$a van der Heijden, Antoine G $u Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands $1 https://orcid.org/0000000288398601
700    1_
$a Giannarini, Gianluca $u Urology Unit, Academic Medical Centre "Santa Maria della Misericordia", Udine, Italy $1 https://orcid.org/000000026995246X
700    1_
$a Girometti, Rossano $u Institute of Radiology, Academic Medical Centre "Santa Maria della Misericordia", Udine, Italy
700    1_
$a Mertens, Laura $u Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Amsterdam, The Netherlands
700    1_
$a Takeuchi, Mitsuru $u Department of Radiology, Radiolonet Tokai, Nagoya, Japan
700    1_
$a Muglia, Valdair F $u Department of Medical Images, Radiation Therapy and Oncohematology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil $1 https://orcid.org/0000000247000599
700    1_
$a Narumi, Yoshifumi $u Department of Healthcare, Tachibana University, Kyoto, Japan
700    1_
$a Novara, Giacomo $u Department of Surgery, Oncology, and Gastroenterology - Urology Clinic, University of Padua, Padua, Italy $1 https://orcid.org/0000000346935058
700    1_
$a Pecoraro, Martina $u Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy
700    1_
$a Roupret, Morgan $u Department of Urology, Sorbonne University, AP-HP, Pitié Salpétrière Hospital, Paris, France
700    1_
$a Sanguedolce, Francesco $u Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain $u Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy $1 https://orcid.org/0000000252427060
700    1_
$a Santini, Daniele $u Division of Medical Oncology A, Policlinico Umberto I, Rome, Italy $u Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic $u Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria
700    1_
$a Simone, Giuseppe $u IRCCS "Regina Elena" National Cancer Institute, Department of Urology, Rome, Italy $1 https://orcid.org/0000000248689025
700    1_
$a Vargas, Hebert A $u Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
700    1_
$a Woo, Sungmin $u Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
700    1_
$a Barentsz, Jelle $u Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, The Netherlands
700    1_
$a Witjes, J Alfred $u Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands
773    0_
$w MED00184385 $t Nature reviews. Urology $x 1759-4820 $g Roč. 21, č. 4 (2024), s. 243-251
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38036666 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134219 $b ABA008
999    __
$a ok $b bmc $g 2143951 $s 1226369
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 21 $c 4 $d 243-251 $e 20231130 $i 1759-4820 $m Nature reviews. Urology $n Nat Rev Urol $x MED00184385
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...